LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 12

Search options

  1. Article ; Online: Functional characterization of NAD dependent de-acetylases SIRT1 and SIRT2 in B-Cell Chronic Lymphocytic Leukemia (CLL).

    Bhalla, Savita / Gordon, Leo I

    Cancer biology & therapy

    2016  Volume 17, Issue 3, Page(s) 300–309

    Abstract: Sirtuins (SIRT) are nicotinamide adenine dinucleotide (NAD+) dependent deacetylases or ADP- ribosyl transferases (ARTs) that deacetylate lysine residues on various proteins regulating a variety of cellular and metabolic processes. These enzymes regulate ... ...

    Abstract Sirtuins (SIRT) are nicotinamide adenine dinucleotide (NAD+) dependent deacetylases or ADP- ribosyl transferases (ARTs) that deacetylate lysine residues on various proteins regulating a variety of cellular and metabolic processes. These enzymes regulate metabolism, cell survival, differentiation and DNA repair. SIRT proteins play an important role in the survival and drug resistance of cancer cells. The purpose of the present study was to investigate the expression and role of SIRT in chronic lymphocytic leukemia (CLL). We analyzed the expression of SIRT1 and SIRT2 in CLL and normal B cells using the Oncomine database as well as by Western blotting of fresh CLL cells from patients and pro-lymphocytic leukemia (PLL) cell lines, JVM-3 and MEC-2. We showed that both primary CLL cells and JVM-3 and MEC-2 cell lines overexpress high levels of functional SIRT1 and SIRT2. SIRT inhibitors EX-527 and sirtinol impair cell growth, induce ROS production, loss of mitochondrial membrane potential and apoptosis in primary CLL cells and cell lines. Using shRNA knock down of SIRT1 and SIRT2 in JVM-3 and MEC-2 cell lines, we showed that expression of both proteins is crucial for the survival of these cells. Furthermore, studies in nutrient deprived conditions suggest a role of SIRT in metabolism in CLL. These results demonstrate that the inhibition of SIRT1 and SIRT2 activity may be a new therapeutic approach for CLL.
    MeSH term(s) Acetylation ; Apoptosis/drug effects ; Carbazoles/pharmacology ; Cell Line, Tumor ; Gene Knockdown Techniques ; Humans ; Leukemia, Lymphocytic, Chronic, B-Cell/enzymology ; Leukemia, Lymphocytic, Chronic, B-Cell/metabolism ; Leukemia, Lymphocytic, Chronic, B-Cell/pathology ; Membrane Potential, Mitochondrial ; NAD/metabolism ; RNA, Small Interfering/genetics ; Reactive Oxygen Species/metabolism ; Sirtuin 1/genetics ; Sirtuin 1/metabolism ; Sirtuin 2/genetics ; Sirtuin 2/metabolism ; Superoxides/metabolism ; Tubulin/metabolism ; Up-Regulation
    Chemical Substances 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide ; Carbazoles ; RNA, Small Interfering ; Reactive Oxygen Species ; Tubulin ; NAD (0U46U6E8UK) ; Superoxides (11062-77-4) ; SIRT1 protein, human (EC 3.5.1.-) ; SIRT2 protein, human (EC 3.5.1.-) ; Sirtuin 1 (EC 3.5.1.-) ; Sirtuin 2 (EC 3.5.1.-)
    Language English
    Publishing date 2016-01-21
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2146305-0
    ISSN 1555-8576 ; 1538-4047
    ISSN (online) 1555-8576
    ISSN 1538-4047
    DOI 10.1080/15384047.2016.1139246
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Novel Use of Targeted Therapy via PARP-Inhibition in a Rare Form of Papillary Renal Cell Carcinoma: A Case Report and Literature Review.

    Olson, Daniel / Bhalla, Savita / Yang, Ximing / Martone, Brenda / Kuzel, Timothy M

    Clinical genitourinary cancer

    2016  Volume 14, Issue 4, Page(s) e445–8

    Language English
    Publishing date 2016
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2225121-2
    ISSN 1938-0682 ; 1558-7673
    ISSN (online) 1938-0682
    ISSN 1558-7673
    DOI 10.1016/j.clgc.2016.03.012
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Paradoxical regulation of hypoxia inducible factor-1α (HIF-1α) by histone deacetylase inhibitor in diffuse large B-cell lymphoma.

    Bhalla, Savita / Evens, Andrew M / Prachand, Sheila / Schumacker, Paul T / Gordon, Leo I

    PloS one

    2013  Volume 8, Issue 11, Page(s) e81333

    Abstract: Hypoxia inducible factor (HIF) is important in cancer, as it regulates various oncogenic genes as well as genes involved in cell survival, proliferation, and migration. Elevated HIF-1 protein promotes a more aggressive tumor phenotype, and greater HIF-1 ... ...

    Abstract Hypoxia inducible factor (HIF) is important in cancer, as it regulates various oncogenic genes as well as genes involved in cell survival, proliferation, and migration. Elevated HIF-1 protein promotes a more aggressive tumor phenotype, and greater HIF-1 expression has been demonstrated to correlate with poorer prognosis, increased risk of metastasis and increased mortality. Recent reports suggest that HIF-1 activates autophagy, a lysosomal degradation pathway which may promote tumor cell survival. We show here that HIF-1α expression is constitutively active in multiple diffuse large B cell lymphoma (DLBCL) cell lines under normoxia and it is regulated by the PI3K/AKT pathway. PCI-24781, a pan histone deacetylase inhibitor (HDACI), enhanced accumulation of HIF-1α and induced autophagy initially, while extended incubation with the drug resulted in inhibition of HIF-1α. We tested the hypothesis that PCI-24781- induced autophagy is mediated by HIF-1α and that inhibition of HIF-1α in these cells results in attenuation of autophagy and decreased survival. We also provide evidence that autophagy serves as a survival pathway in DLBCL cells treated with PCI-24781 which suggests that the use of autophagy inhibitors such as chloroquine or 3-methyl adenine in combination with PCI-24781 may enhance apoptosis in lymphoma cells.
    MeSH term(s) AMP-Activated Protein Kinases/metabolism ; Autophagy/drug effects ; Benzofurans/pharmacology ; Cell Survival/drug effects ; Drug Synergism ; Enzyme Activation/drug effects ; Gene Expression Regulation, Neoplastic/drug effects ; Histone Deacetylase Inhibitors/pharmacology ; Humans ; Hydroxamic Acids/pharmacology ; Hypoxia-Inducible Factor 1, alpha Subunit/metabolism ; Lymphoma, Large B-Cell, Diffuse/pathology ; Phosphatidylinositol 3-Kinases/metabolism ; Proto-Oncogene Proteins c-akt/metabolism ; Signal Transduction/drug effects
    Chemical Substances Benzofurans ; HIF1A protein, human ; Histone Deacetylase Inhibitors ; Hydroxamic Acids ; Hypoxia-Inducible Factor 1, alpha Subunit ; Phosphatidylinositol 3-Kinases (EC 2.7.1.-) ; Proto-Oncogene Proteins c-akt (EC 2.7.11.1) ; AMP-Activated Protein Kinases (EC 2.7.11.31) ; abexinostat (IYO470654U)
    Language English
    Publishing date 2013-11-27
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ISSN 1932-6203
    ISSN (online) 1932-6203
    DOI 10.1371/journal.pone.0081333
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: The novel organic arsenical darinaparsin induces MAPK-mediated and SHP1-dependent cell death in T-cell lymphoma and Hodgkin lymphoma cells and human xenograft models.

    Ravi, Dashnamoorthy / Bhalla, Savita / Gartenhaus, Ronald B / Crombie, Jennifer / Kandela, Irawati / Sharma, Jaya / Mazar, Andrew / Evens, Andrew M

    Clinical cancer research : an official journal of the American Association for Cancer Research

    2014  Volume 20, Issue 23, Page(s) 6023–6033

    Abstract: Purpose: Darinaparsin (Zio-101) is a novel organic arsenical compound with encouraging clinical activity in relapsed/refractory T-cell lymphoma (TCL) and Hodgkin lymphoma (HL); however, little is known about its mechanism of action.: Experimental ... ...

    Abstract Purpose: Darinaparsin (Zio-101) is a novel organic arsenical compound with encouraging clinical activity in relapsed/refractory T-cell lymphoma (TCL) and Hodgkin lymphoma (HL); however, little is known about its mechanism of action.
    Experimental design: TCL cell lines (Jurkat, Hut78, and HH) and HL cell lines (L428, L540, and L1236) were examined for in vitro cell death by MTT assay and Annexin V-based flow cytometry. Jurkat and L540-derived xenografts in SCID mice were examined for in vivo tumor inhibition and survival. Biologic effects of darinaparsin on the MAPK pathway were investigated using pharmacologic inhibitors, RNAi and transient transfection for overexpression for SHP1 and MEK.
    Results: Darinaparsin treatment resulted in time- and dose-dependent cytotoxicity and apoptosis in all TCL and HL cell lines. In addition, darinaparsin had more rapid, higher, and sustained intracellular arsenic levels compared with arsenic trioxide via mass spectrometry. In vivo experiments with Jurkat (TCL) and L540 (HL)-derived lymphoma xenografts showed significant inhibition of tumor growth and improved survival in darinaparsin-treated SCID mice. Biologically, darinaparsin caused phosphorylation of ERK (and relevant downstream substrates) primarily by decreasing the inhibitory SHP1 phosphatase and coimmunoprecipitation showed significant ERK/SHP1 interaction. Furthermore, ERK shRNA knockdown or constitutive overexpression of SHP1 resulted in increased apoptosis, whereas cotreatment with pharmacologic MEK inhibitors resulted in synergistic cell death. Conversely, SHP1 blockade (via pharmacologic inhibition or RNAi) and MEK constitutive activation decreased darinaparsin-related cell death.
    Conclusions: Altogether, these data show that darinaparsin is highly active in HL and TCL and its activity is dependent primarily on MAPK mechanisms.
    MeSH term(s) Animals ; Apoptosis/drug effects ; Arsenic/metabolism ; Arsenicals/administration & dosage ; Arsenicals/pharmacology ; Cell Cycle/drug effects ; Cell Death/drug effects ; Cell Line, Tumor ; Cell Survival/drug effects ; Disease Models, Animal ; Extracellular Signal-Regulated MAP Kinases/metabolism ; Glutathione/administration & dosage ; Glutathione/analogs & derivatives ; Glutathione/pharmacology ; Hodgkin Disease/drug therapy ; Hodgkin Disease/metabolism ; Hodgkin Disease/mortality ; Hodgkin Disease/pathology ; Humans ; Intracellular Space/metabolism ; Lymphoma, T-Cell/drug therapy ; Lymphoma, T-Cell/metabolism ; Lymphoma, T-Cell/mortality ; Lymphoma, T-Cell/pathology ; Mice ; Mitogen-Activated Protein Kinases/metabolism ; Protein Tyrosine Phosphatase, Non-Receptor Type 6/metabolism ; Signal Transduction/drug effects ; Tumor Burden/drug effects ; Xenograft Model Antitumor Assays
    Chemical Substances Arsenicals ; darinaparsin (9XX54M675G) ; Extracellular Signal-Regulated MAP Kinases (EC 2.7.11.24) ; Mitogen-Activated Protein Kinases (EC 2.7.11.24) ; Protein Tyrosine Phosphatase, Non-Receptor Type 6 (EC 3.1.3.48) ; Glutathione (GAN16C9B8O) ; Arsenic (N712M78A8G)
    Language English
    Publishing date 2014-10-14
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 1225457-5
    ISSN 1557-3265 ; 1078-0432
    ISSN (online) 1557-3265
    ISSN 1078-0432
    DOI 10.1158/1078-0432.CCR-14-1532
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: The novel anti-MEK small molecule AZD6244 induces BIM-dependent and AKT-independent apoptosis in diffuse large B-cell lymphoma.

    Bhalla, Savita / Evens, Andrew M / Dai, Bojie / Prachand, Sheila / Gordon, Leo I / Gartenhaus, Ronald B

    Blood

    2011  Volume 118, Issue 4, Page(s) 1052–1061

    Abstract: The RAS/RAF/MEK/ERK signaling pathway has been largely unexplored as a potential therapeutic target in lymphoma. The novel 2nd generation anti-MEK small molecule, AZD6244, down-regulated its direct downstream target, phospho-ERK (pERK) in germinal center ...

    Abstract The RAS/RAF/MEK/ERK signaling pathway has been largely unexplored as a potential therapeutic target in lymphoma. The novel 2nd generation anti-MEK small molecule, AZD6244, down-regulated its direct downstream target, phospho-ERK (pERK) in germinal center and nongerminal center diffuse large B-cell lymphoma (DLBCL) cell lines and primary cells. Similar decreased pERK levels were noted despite constitutive activation (CA) of MEK. Consequently, several lymphoma-related ERK substrates were down-regulated by AZD6244 including MCT-1, c-Myc, Bcl-2, Mcl-1, and CDK1/2. AZD6244 induced time- and dose-dependent antiproliferation and apoptosis in all DLBCL cell lines and fresh/primary cells (IC(50) 100nM-300nM). Furthermore, AZD6244 resulted in significantly less tumor compared with control in an in vivo DLBCL SCID xenograft model. Cell death was associated with cleaved PARP, caspases-8, -9, and -3, and apoptosis was caspase-dependent. In addition, there was stabilization of FoxO3a, activation of BIM and PUMA, and a significant decrease in c-Myc transcripts. Moreover, siRNA knockdown of BIM abrogated AZD6244-related apoptosis, while shRNA knockdown of ERK minimally sensitized cells. Finally, manipulation of AKT with transfection of OCI-LY3 cells with CA-AKT or through chemical inhibition (LY294002) had minimal effect on AZD6244-induced cell death. Altogether, these findings show that the novel anti-MEK agent, AZD6244, induced apoptosis in DLBCL and that cell death was BIM-dependent.
    MeSH term(s) Animals ; Antineoplastic Agents/pharmacology ; Apoptosis/drug effects ; Apoptosis Regulatory Proteins/metabolism ; Bcl-2-Like Protein 11 ; Benzimidazoles/pharmacology ; Blotting, Western ; Cell Line, Tumor ; Female ; Humans ; Lymphoma, Large B-Cell, Diffuse/metabolism ; MAP Kinase Kinase Kinases/antagonists & inhibitors ; Membrane Proteins/metabolism ; Mice ; Mice, SCID ; Protein Kinase Inhibitors/pharmacology ; Proto-Oncogene Proteins/metabolism ; Proto-Oncogene Proteins c-akt/metabolism ; Signal Transduction/drug effects ; Transfection ; Xenograft Model Antitumor Assays
    Chemical Substances AZD 6244 ; Antineoplastic Agents ; Apoptosis Regulatory Proteins ; BCL2L11 protein, human ; Bcl-2-Like Protein 11 ; Bcl2l11 protein, mouse ; Benzimidazoles ; Membrane Proteins ; Protein Kinase Inhibitors ; Proto-Oncogene Proteins ; Proto-Oncogene Proteins c-akt (EC 2.7.11.1) ; MAP Kinase Kinase Kinases (EC 2.7.11.25)
    Language English
    Publishing date 2011-05-31
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 80069-7
    ISSN 1528-0020 ; 0006-4971
    ISSN (online) 1528-0020
    ISSN 0006-4971
    DOI 10.1182/blood-2011-03-340109
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Mitochondrial-mediated apoptosis in lymphoma cells by the diterpenoid lactone andrographolide, the active component of Andrographis paniculata.

    Yang, Shuo / Evens, Andrew M / Prachand, Sheila / Singh, Amareshwar T K / Bhalla, Savita / David, Kevin / Gordon, Leo I

    Clinical cancer research : an official journal of the American Association for Cancer Research

    2010  Volume 16, Issue 19, Page(s) 4755–4768

    Abstract: Purpose: Andrographolide is a diterpenoid lactone isolated from Andrographis paniculata (King of Bitters), an herbal medicine used in Asia. It has been reported to have anti-inflammatory, antihypertensive, antiviral, and immune-stimulant properties. ... ...

    Abstract Purpose: Andrographolide is a diterpenoid lactone isolated from Andrographis paniculata (King of Bitters), an herbal medicine used in Asia. It has been reported to have anti-inflammatory, antihypertensive, antiviral, and immune-stimulant properties. Furthermore, it has been shown to inhibit cancer cell proliferation and induce apoptosis in leukemia and solid tumor cell lines.
    Experimental design: We studied the Burkitt p53-mutated Ramos cell line, the mantle cell lymphoma (MCL) line Granta, the follicular lymphoma (FL) cell line HF-1, and the diffuse large B-cell lymphoma (DLBCL) cell line SUDHL4, as well as primary cells from patients with FL, DLBCL, and MCL.
    Results: We found that andrographolide resulted in dose- and time-dependent cell death as measured by MTT. Andrographolide significantly increased reactive oxygen species (ROS) production in all cell lines. To determine mechanism of cell death, we measured apoptosis by Annexin V/propidium iodide in the presence and absence of the antioxidant N-acetyl-l-cysteine (NAC), the glutathione (GSH)-depleting agent buthionine sulfoxamine (BSO), or caspase inhibitors. We found that apoptosis was greatly enhanced by BSO, blocked by NAC, and accompanied by poly(ADP-ribose) polymerase cleavage and activation of caspase-3, caspase-8, and caspase-9. We measured BAX conformational change and mitochondrial membrane potential, and using mouse embryonic fibroblast (MEF) Bax/Bak double knockouts (MEF(Bax-/-/Bak-/-)), we found that apoptosis was mediated through mitochondrial pathways, but dependent on caspases in both cell lines and patient samples.
    Conclusions: Andrographolide caused ROS-dependent apoptosis in lymphoma cell lines and in primary tumor samples, which was enhanced by depletion of GSH and inhibited by NAC or the pan-caspase inhibitor Z-VAD-FMK. Further studies of diterpenoid lactones in lymphoma are warranted.
    MeSH term(s) Andrographis/chemistry ; Animals ; Antineoplastic Agents/chemistry ; Antineoplastic Agents/isolation & purification ; Antineoplastic Agents/pharmacology ; Apoptosis/drug effects ; Cell Line, Tumor ; Cell Proliferation/drug effects ; Cell Survival/drug effects ; Diterpenes/chemistry ; Diterpenes/isolation & purification ; Diterpenes/pharmacology ; Dose-Response Relationship, Drug ; Drug Screening Assays, Antitumor ; Fibroblasts/cytology ; Fibroblasts/drug effects ; Humans ; Lymphoma/drug therapy ; Lymphoma/metabolism ; Lymphoma/pathology ; Membrane Potential, Mitochondrial/drug effects ; Mice ; Mice, Knockout ; Mitochondria/drug effects ; Mitochondria/metabolism ; Reactive Oxygen Species/metabolism ; Time Factors
    Chemical Substances Antineoplastic Agents ; Diterpenes ; Reactive Oxygen Species ; andrographolide (410105JHGR)
    Language English
    Publishing date 2010-08-26
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 1225457-5
    ISSN 1557-3265 ; 1078-0432
    ISSN (online) 1557-3265
    ISSN 1078-0432
    DOI 10.1158/1078-0432.CCR-10-0883
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: differential roles for the E2A activation domains in B lymphocytes and macrophages.

    Bhalla, Savita / Spaulding, Christina / Brumbaugh, Rachel L / Zagort, Derek E / Massari, Mark E / Murre, Cornelis / Kee, Barbara L

    Journal of immunology (Baltimore, Md. : 1950)

    2008  Volume 180, Issue 3, Page(s) 1694–1703

    Abstract: The E2A gene encodes two E protein/class I basic helix-loop-helix transcription factors, E12 and E47, that are essential for B lymphopoiesis. In addition to the DNA-binding and protein dimerization domain, the E proteins share two highly conserved ... ...

    Abstract The E2A gene encodes two E protein/class I basic helix-loop-helix transcription factors, E12 and E47, that are essential for B lymphopoiesis. In addition to the DNA-binding and protein dimerization domain, the E proteins share two highly conserved transcription activation domains. In this study, we show that both activation domains are required for optimal E2A-dependent transcription. Surprisingly, however, neither activation domain is required for E2A to rescue B lymphopoiesis from E2A(-/-) hemopoietic progenitors, although the N terminus of E2A, which harbors some transcription capacity, is required. Therefore, the E protein activation domains function redundantly in promoting B cell development. In contrast, the N-terminal activation domain, AD1, is required for a newly described ability of E2A to suppress macrophage development in vitro. Our findings demonstrate distinct functionalities for the E protein activation domains in B lymphocytes and macrophages.
    MeSH term(s) Animals ; B-Lymphocytes/immunology ; Basic Helix-Loop-Helix Transcription Factors/genetics ; Basic Helix-Loop-Helix Transcription Factors/physiology ; CD11b Antigen/analysis ; Lymphocyte Activation/genetics ; Macrophage Activation/genetics ; Macrophages/immunology ; Mice ; Mice, Mutant Strains ; Mutation ; Protein Structure, Tertiary/physiology ; Transcriptional Activation
    Chemical Substances Basic Helix-Loop-Helix Transcription Factors ; CD11b Antigen ; Tcf3 protein, mouse
    Language English
    Publishing date 2008-01-21
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 3056-9
    ISSN 1550-6606 ; 0022-1767 ; 1048-3233 ; 1047-7381
    ISSN (online) 1550-6606
    ISSN 0022-1767 ; 1048-3233 ; 1047-7381
    DOI 10.4049/jimmunol.180.3.1694
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Glutathione depletion enhances arsenic trioxide-induced apoptosis in lymphoma cells through mitochondrial-independent mechanisms.

    Bhalla, Savita / Gordon, Leo I / David, Kevin / Prachand, Sheila / Singh, Amareshwar T K / Yang, Shuo / Winter, Jane N / Guo, Dongsheng / O'Halloran, Thomas / Platanias, Leonidas C / Evens, Andrew M

    British journal of haematology

    2010  Volume 150, Issue 3, Page(s) 365–369

    MeSH term(s) Antineoplastic Agents/pharmacology ; Apoptosis/drug effects ; Arsenic Trioxide ; Arsenicals/pharmacology ; Glutathione/physiology ; Humans ; Lymphoma/pathology ; Mitochondria/physiology ; Oxides/pharmacology
    Chemical Substances Antineoplastic Agents ; Arsenicals ; Oxides ; Glutathione (GAN16C9B8O) ; Arsenic Trioxide (S7V92P67HO)
    Language English
    Publishing date 2010-04-16
    Publishing country England
    Document type Letter ; Research Support, N.I.H., Extramural ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 80077-6
    ISSN 1365-2141 ; 0007-1048
    ISSN (online) 1365-2141
    ISSN 0007-1048
    DOI 10.1111/j.1365-2141.2010.08197.x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: All trans retinoic acid nanodisks enhance retinoic acid receptor mediated apoptosis and cell cycle arrest in mantle cell lymphoma.

    Singh, Amareshwar T K / Evens, Andrew M / Anderson, Reilly J / Beckstead, Jennifer A / Sankar, Natesan / Sassano, Antonella / Bhalla, Savita / Yang, Shuo / Platanias, Leonidas C / Forte, Trudy M / Ryan, Robert O / Gordon, Leo I

    British journal of haematology

    2010  Volume 150, Issue 2, Page(s) 158–169

    Abstract: Mantle cell lymphoma (MCL) is characterized by translocation t(11;14)(q13;q32), aggressive clinical behaviour, and poor patient outcomes following conventional chemotherapy. New treatment approaches are needed that target novel biological pathways. All ... ...

    Abstract Mantle cell lymphoma (MCL) is characterized by translocation t(11;14)(q13;q32), aggressive clinical behaviour, and poor patient outcomes following conventional chemotherapy. New treatment approaches are needed that target novel biological pathways. All trans retinoic acid (ATRA) is a key retinoid that acts through nuclear receptors that function as ligand-inducible transcription factors. The present study evaluated cell killing effects of ATRA-enriched nanoscale delivery particles, termed nanodisks (ND), on MCL cell lines. Results show that ATRA-ND induced cell death more effectively than naked ATRA (dimethyl sulphoxide) or empty ND. ATRA-ND induced reactive oxygen species (ROS) generation to a greater extent than naked ATRA. The antioxidant, N-acetylcysteine, inhibited ATRA-ND induced apoptosis. Compared to naked ATRA, ATRA-ND enhanced G1 growth arrest, up-regulated p21and p27, and down regulated cyclin D1. At ATRA concentrations that induced apoptosis, expression levels of retinoic acid receptor-alpha (RARalpha) and retinoid X receptor-gamma (RXRgamma) were increased. Compared to naked ATRA, ATRA-ND significantly stimulated transcriptional activity of RARA in a model carcinoma cell line. Furthermore, the RAR antagonist, Ro 41-5253, inhibited ATRA-ND induced ROS generation and prevented ATRA-ND induced cell growth arrest and apoptosis. In summary, incorporation of ATRA into ND enhanced the biological activity of this retinoid in cell culture models of MCL.
    MeSH term(s) Antineoplastic Agents/administration & dosage ; Antineoplastic Agents/pharmacology ; Apoptosis/drug effects ; Benzoates/pharmacology ; Cell Cycle/drug effects ; Cell Cycle Proteins/biosynthesis ; Cell Cycle Proteins/drug effects ; Chromans/pharmacology ; Drug Delivery Systems ; Drug Evaluation, Preclinical ; Guanine Nucleotide Exchange Factors/biosynthesis ; Guanine Nucleotide Exchange Factors/drug effects ; Humans ; Lymphoma, Mantle-Cell/metabolism ; Lymphoma, Mantle-Cell/pathology ; Nanoparticles ; Neoplasm Proteins/biosynthesis ; Neoplasm Proteins/drug effects ; Nuclear Proteins/biosynthesis ; Nuclear Proteins/drug effects ; Reactive Oxygen Species/metabolism ; Receptors, Retinoic Acid/antagonists & inhibitors ; Receptors, Retinoic Acid/drug effects ; Receptors, Retinoic Acid/metabolism ; Retinoid X Receptors/drug effects ; Retinoid X Receptors/metabolism ; Transcription, Genetic/drug effects ; Tretinoin/administration & dosage ; Tretinoin/pharmacology ; Tumor Cells, Cultured
    Chemical Substances Antineoplastic Agents ; Benzoates ; Cell Cycle Proteins ; Chromans ; Guanine Nucleotide Exchange Factors ; Neoplasm Proteins ; Nuclear Proteins ; RCC1 protein, human ; Reactive Oxygen Species ; Receptors, Retinoic Acid ; Retinoid X Receptors ; Ro 41-5253 (144092-31-9) ; Tretinoin (5688UTC01R)
    Language English
    Publishing date 2010-05-09
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 80077-6
    ISSN 1365-2141 ; 0007-1048
    ISSN (online) 1365-2141
    ISSN 0007-1048
    DOI 10.1111/j.1365-2141.2010.08209.x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: PCI-24781 induces caspase and reactive oxygen species-dependent apoptosis through NF-kappaB mechanisms and is synergistic with bortezomib in lymphoma cells.

    Bhalla, Savita / Balasubramanian, Sriram / David, Kevin / Sirisawad, Mint / Buggy, Joseph / Mauro, Lauren / Prachand, Sheila / Miller, Richard / Gordon, Leo I / Evens, Andrew M

    Clinical cancer research : an official journal of the American Association for Cancer Research

    2009  Volume 15, Issue 10, Page(s) 3354–3365

    Abstract: Purpose: We investigated the cytotoxicity and mechanisms of cell death of the broad-spectrum histone deacetylase (HDAC) inhibitor PCI-24781, alone and combined with bortezomib in Hodgkin lymphoma and non-Hodgkin lymphoma cell lines and primary ... ...

    Abstract Purpose: We investigated the cytotoxicity and mechanisms of cell death of the broad-spectrum histone deacetylase (HDAC) inhibitor PCI-24781, alone and combined with bortezomib in Hodgkin lymphoma and non-Hodgkin lymphoma cell lines and primary lymphoproliferative (CLL/SLL) cells.
    Experimental design: Apoptosis, mitochondrial membrane potential, cell cycle analysis, and reactive oxygen species (ROS) were measured by flow cytometry, whereas caspase activation was determined by Western blot. Nuclear factor kappaB (NF-kappaB)-related mRNAs were quantified by reverse transcription-PCR, NF-kappaB-related proteins by Western blotting, and NF-kappaB DNA-binding activity by electromobility shift assay. Finally, gene expression profiling was analyzed.
    Results: PCI-24781 induced concentration-dependent apoptosis that was associated with prominent G(0)/G(1) arrest, decreased S-phase, increased p21 protein, and increased ROS in Hodgkin lymphoma and non-Hodgkin lymphoma cell lines. Dose-dependent apoptosis with PCI-24781 was also seen among primary CLL/SLL cells. PCI-24781-induced apoptosis was shown to be ROS- and caspase-dependent. Combined PCI-24781/bortezomib treatment resulted in strong synergistic apoptosis in all non-Hodgkin lymphoma lines (combination indices, 0.19-0.6) and was additive in Hodgkin lymphoma and primary CLL/SLL cells. Further, PCI-24781/bortezomib resulted in increased caspase cleavage, mitochondrial depolarization, and histone acetylation compared with either agent alone. Gene expression profiling showed that PCI-24781 alone significantly down-regulated several antioxidant genes, proteasome components, and NF-kappaB pathway genes, effects that were enhanced further with bortezomib. Reverse transcription-PCR confirmed down-regulation of NF-kappaB1 (p105), c-Myc, and IkappaB-kinase subunits, where NF-kappaB DNA binding activity was decreased.
    Conclusion: We show that PCI-24781 results in increased ROS and NF-kappaB inhibition, leading to caspase-dependent apoptosis. We also show that bortezomib is synergistic with PCI-24781. This combination or PCI-24781 alone has potential therapeutic value in lymphoma.
    MeSH term(s) Aged ; Antineoplastic Agents/pharmacology ; Apoptosis/drug effects ; Apoptosis/genetics ; Benzofurans/pharmacology ; Blotting, Western ; Boronic Acids/pharmacology ; Bortezomib ; Caspases/metabolism ; Cell Cycle/drug effects ; Cell Line, Tumor ; Dose-Response Relationship, Drug ; Drug Synergism ; Female ; Flow Cytometry ; Gene Expression Profiling ; Gene Expression Regulation, Neoplastic/drug effects ; Histone Deacetylase Inhibitors ; Humans ; Hydroxamic Acids/pharmacology ; Lymphoma/genetics ; Lymphoma/metabolism ; Lymphoma/pathology ; Lymphoma, Non-Hodgkin/genetics ; Lymphoma, Non-Hodgkin/metabolism ; Lymphoma, Non-Hodgkin/pathology ; Male ; Membrane Potential, Mitochondrial/drug effects ; Middle Aged ; NF-kappa B/metabolism ; Pyrazines/pharmacology ; Reactive Oxygen Species/metabolism ; Tumor Cells, Cultured
    Chemical Substances Antineoplastic Agents ; Benzofurans ; Boronic Acids ; Histone Deacetylase Inhibitors ; Hydroxamic Acids ; NF-kappa B ; Pyrazines ; Reactive Oxygen Species ; Bortezomib (69G8BD63PP) ; Caspases (EC 3.4.22.-) ; abexinostat (IYO470654U)
    Language English
    Publishing date 2009-05-05
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 1225457-5
    ISSN 1557-3265 ; 1078-0432
    ISSN (online) 1557-3265
    ISSN 1078-0432
    DOI 10.1158/1078-0432.CCR-08-2365
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top